We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Munch-a-Biotech Today
An SI Board Since December 1998
Posts SubjectMarks Bans
3158 144 0
Emcee:  Biomaven Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3133So, generic "THALIDOMIDE" derivatives are worth $74B, after they "Miljenko Zuanic-1/3/2019
3132BMY takes out Celgene for 1 BMY share + $50 per share of CELG. About $102/sharetuck11/3/2019
3131GSK takes out Tesaro (TSRO). I don't get it. They seem to me like somethingtuck-12/3/2018
3130Reuters) - U.S. medical device maker Boston Scientific Corp (BSX.N) said it had nigel bates-11/20/2018
3129STOCKHOLM (Reuters) - Private equity firm EQT on Monday made a recommended 5.97 nigel bates-10/29/2018
3128Endocyte / Novartis: WEST LAFAYETTE, Ind., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Ennigel bates-10/18/2018
3127This is perhaps more interesting than the size of the deal would suggest. (And tnigel bates18/9/2018
3126Roche taking out Foundation Medicine (FMI). Cheers, Tucktuck-6/19/2018
3125Sanofi further committing to develop nanobodies with Ablynx: GHENT, Belgium, 16nigel bates-2/16/2018
3124Yes, it's the company's own 10b5-1 (buying) plan. It's not necessaryDewDiligence_on_SI-2/1/2018
3123<The 10b5-1 plan VRTX is talking about in the PR is for the company's ownMiljenko Zuanic-1/31/2018
3122It is for the open market, as well for negotiated private transactions, that is Miljenko Zuanic-1/31/2018
3121The 10b5-1 plan VRTX is talking about in the PR is for the company's own buyDewDiligence_on_SI-1/31/2018
3120<..privately negotiated transactions and may be made pursuant to Rule 10b5-1 Miljenko Zuanic-1/31/2018
3119This is not a $500M grant to insiders. (Not sure if your question was facetious.DewDiligence_on_SI-1/31/2018
3118RE: VRTX "Stock Repurchase Program" <The company today announced Miljenko Zuanic-1/31/2018
3117SGEN munching CASC...mopgcw-1/31/2018
3116I would guess quite a number will leave. By all accounts, Ablynx seems to have bnigel bates-1/29/2018
3115Yes, but do you think that scientist and mid-level management will prosper underMiljenko Zuanic-1/29/2018
3114Maybe just that the large shareholders wanted to sell ? And it's a better fnigel bates-1/29/2018
3113Why was Ablynx BofD inclined to sell comp so early? Aware of risk involved, or..Miljenko Zuanic-1/29/2018
3112Sanofi rides in as white knight - though I still think it's being sold cheapnigel bates-1/29/2018
3111Sanofi to Acquire Bioverativ for $11.6 Billion Expands Sanofi's presence innigel bates-1/22/2018
3110Interesting interview (pre-bid) with Ed Moses: His comments arnigel bates-1/17/2018
3109Not the only one [graphic] January 16, 2018 01:01 ET olivier benrubi-1/16/2018
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):